{
    "clinical_study": {
        "@rank": "144688", 
        "arm_group": {
            "arm_group_label": "Individuals undergoing skin excision.", 
            "description": "Skin lesions are under suspicion for skin cancer."
        }, 
        "brief_summary": {
            "textblock": "In this study a fluorescent contrast dye is applied to a suspicious skin lesion.\n\n      Images are acquired and processed. The information is used to develop a prediction model for\n      the presence of malignant transformation in the skin."
        }, 
        "brief_title": "Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Skin Lesions", 
        "detailed_description": {
            "textblock": "Images acquired in the study are used for the development of a software analysis program."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Over the age of 18\n\n          -  Individual is scheduled for a skin biopsy in toto\n\n          -  The lesion is pigmented or non pigmented\n\n          -  Lesions may be under suspicion for basal cell carcinoma, squamous cell carcinoma,\n             actinic keratosis, nevi, melanoma, seborrheic keratosis.\n\n          -  The lesion is accessible to the imaging device\n\n        Exclusion Criteria:\n\n          -  The patient has sensitive skin and easily breaks out in rash\n\n          -  The lesion is within 1 cm of the eye\n\n          -  The lesion is on mucosal surfaces (e.g., lips, genitals)\n\n          -  Pregnant females\n\n          -  Taking medications that pigments the skin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients above 18 years scheduled for a skin biopsy."
            }
        }, 
        "enrollment": {
            "#text": "126", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009085", 
            "org_study_id": "KH 2012"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2013", 
        "number_of_groups": "1", 
        "official_title": "Pilot Study to Asses the Identification of Melanoma in Skin Lesions.", 
        "other_outcome": {
            "description": "no other outcome is specified in the .", 
            "measure": "None specified.", 
            "safety_issue": "No", 
            "time_frame": "0"
        }, 
        "overall_official": {
            "affiliation": "Rambam Health Care Campus", 
            "last_name": "Yehuda Ullmann, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients are imaged and then undergo a biopsy. Images are used to develop a software predicting model based on pathology. Sensitivity and specificity parameters are calculated.\nNo long term follow up is required since the biopsy is performed on the skin imaged. The follow up required is for the pathology for the skin excised.", 
            "measure": "Correlation between imaging and pathology.", 
            "safety_issue": "No", 
            "time_frame": "No long term follow up is necessary."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009085"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The acute dermal response to the imaging procedure is evaluated.", 
            "measure": "Acute response", 
            "safety_issue": "Yes", 
            "time_frame": "up to 1 day"
        }, 
        "source": "Orlucent, Inc", 
        "sponsors": {
            "collaborator": {
                "agency": "Clalit Health Services", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Orlucent, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}